Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. is convening its first extraordinary general meeting of shareholders in 2025 to discuss significant changes including alterations to the company's registered capital, type, business scope, and governance structure [1][5]. Group 1: Meeting Procedures - Shareholders and their proxies must register 30 minutes before the meeting and present necessary identification to attend [1][2]. - After the meeting starts, attendance registration will cease, and latecomers will not be allowed to vote [2]. - The meeting will follow a predetermined agenda for reviewing and voting on proposals [2][5]. Group 2: Proposals Overview - The primary proposal includes changes to the company's registered capital, type, and business scope, as well as the cancellation of the supervisory board and amendments to the company’s articles of association [5][10]. - The company plans to increase its registered capital from RMB 66 million to RMB 88 million following its initial public offering of 22 million shares on May 16, 2025 [7]. - The business scope will be expanded to include new areas such as mechanical equipment research and development, software development, and various manufacturing activities [7][8]. Group 3: Governance Changes - The company will abolish the supervisory board, transferring its powers to the audit committee of the board of directors [8][9]. - Amendments to the articles of association will be proposed, with the aim of enhancing corporate governance and operational efficiency [10]. - The revised articles and related documents will be disclosed on the Shanghai Stock Exchange website [9][10].

Group 1 - The company held its third board meeting on July 21, 2025, where all directors agreed to waive the advance notice period for the meeting [2] - The board approved the increase of registered capital from 100,643,920 yuan to 101,043,920 yuan following the completion of the second vesting period of the 2022 restricted stock incentive plan [3][40] - The board's resolutions are valid and require shareholder approval [6][10] Group 2 - The board approved a change in the purpose of repurchased shares, with 1,230,216 shares now intended for cancellation to reduce registered capital, decreasing the capital from 101,043,920 yuan to 99,813,704 yuan [7][29] - This change aims to enhance investor returns and confidence, and the decision is based on the company's operational considerations [33][36] - The board's resolutions regarding the repurchase and cancellation of shares also require shareholder approval [10][37] Group 3 - The company plans to hold its first extraordinary general meeting of 2025 on August 6, 2025, using a combination of on-site and online voting [11][14] - The meeting will address the resolutions passed by the board, including the increase of registered capital and the change in the purpose of repurchased shares [17][18] - Shareholders must register to attend the meeting and can vote through the Shanghai Stock Exchange's online voting system [21][22] Group 4 - The company forecasts a revenue of approximately 33 million yuan for the first half of 2025, representing a year-on-year increase of about 35.5% [43] - The net profit attributable to the parent company is expected to be around 3.3 million yuan, marking a turnaround from a loss in the previous year [44] - The improvement in performance is attributed to growth in the commercial vehicle sector and increased sales in the passenger vehicle segment [47]

Core Viewpoint - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss key proposals, including changes to share repurchase purposes and capital reduction, aimed at enhancing shareholder value and maintaining investor confidence [1][8][10] Meeting Procedures - The meeting will verify the identity of attendees and require them to sign in 30 minutes prior to the start [1] - Only shareholders present at the beginning of the meeting will be allowed to vote [2] - Shareholders have the right to speak, inquire, and vote, but must register in advance to speak [2][3] - Voting will be conducted through a combination of on-site and online methods, with each share carrying one vote [3] Proposals - Proposal One: The company plans to increase its registered capital from 100,643,920 yuan to 101,043,920 yuan following the completion of the second vesting period of its 2022 restricted stock incentive plan [6] - Proposal Two: The company intends to change the purpose of its share repurchase, with all 1,230,216 shares being repurchased for cancellation to reduce registered capital [7][8] Share Repurchase Details - Prior to the change, 246,043 shares were intended for employee stock ownership plans, and 984,173 shares were for maintaining company value [8] - After the change, the total number of shares will decrease from 101,043,920 to 99,813,704, representing a reduction of 1.2175% of the total share capital [9][10] - The decision to cancel shares is expected to enhance earnings per share and improve shareholder returns without adversely affecting the company's financial condition or debt servicing ability [9][10]

北方光电股份有限公司 截至 2025 年 7 月 8 日新增注册资本及股 本情况验资报告 信会师报字2025第 ZG12686 号 北方光电股份有限公司 截至 2025 年 7 月 8 日新增注册资本 及股本情况验资报告 目 录 页 次 一、 验资报告 1-2 二、 附件 1 3 附件 2 4 附件 3 5-6 验 资 报 告 信会师报字2025第ZG12686号 北方光电股份有限公司： 我们接受委托，审验了北方光电股份有限公司（以下简称"贵公司" "光电股份"）截至 2025 年 7 月 8 日止新增注册资本及股本情况。按照法 律法规以及协议、章程的要求出资，提供真实、合法、完整的验资资料， 保护资产的安全、完整是全体股东及贵公司的责任。我们的责任是对贵公 司新增注册资本及股本情况发表审验意见。我们的审验是依据《中国注册 会计师审计准则第 1602 号——验资》进行的。在审验过程中，我们结合贵 公司的实际情况，实施了检查等必要的审验程序。 贵公司原注册资本为人民币 508,760,826.00 元，股本为 508,760,826.00 元。根据贵公司第七届董事会第六次会议、第七届监事会第四次会议、2024 ...

Core Points - The stock price of Huatai Medical (688617) increased by 1.22% to 295.0 CNY as of July 11, 2025, with a market capitalization of 41.599 billion CNY, ranking 4th in the medical device sector [1] - The company held its 23rd meeting of the second board of directors on July 7, 2025, where several key resolutions were passed, including changes to registered capital and amendments to the company's articles of association [1][5] - Huatai Medical plans to distribute a cash dividend of 17.50 CNY per 10 shares and to increase capital by 4.5 shares for every 10 shares held, resulting in a total share count increase to 141,013,796 shares [1][5] Company Announcements - The company announced the abandonment of part of its preemptive rights and plans to increase capital by 50 million CNY in its subsidiary, Yiweidi, which focuses on non-vascular interventional business [2][5] - The board approved adjustments to the 2021 restricted stock incentive plan, including changes to grant prices and quantities due to management's request to defer stock vesting [3][5] - The adjustments include a reduction in the grant price for A-class restricted stock from 137.68 CNY to 93.74 CNY and for B-class restricted stock from 123.56 CNY to 84.01 CNY [3]

Core Viewpoint - The company has decided to cancel its supervisory board, change its registered capital, and amend its articles of association, which will be submitted for approval at the upcoming extraordinary general meeting of shareholders [1][2]. Summary by Sections Cancellation of Supervisory Board - The company will no longer have a supervisory board, with its functions transferred to the audit committee of the board of directors. Relevant rules and regulations concerning the supervisory board will be abolished [1][2]. Change in Registered Capital - The company has completed the first grant of the 2020 stock option incentive plan and the fourth exercise period, resulting in a total share registration of 1,191,275 shares. Following this, the total share capital of the company has been adjusted [2]. Amendments to Articles of Association - The company plans to amend several provisions in its articles of association to enhance governance and comply with relevant laws and regulations. Key changes include the uniform modification of "shareholders' meeting" to "shareholders' assembly" and the removal of references to the supervisory board [2][3]. Revision and Formulation of Corporate Governance Systems - The company aims to revise and establish certain corporate governance systems to promote standardized operations and improve internal governance mechanisms. These revisions have been approved by the board of directors and will require shareholder approval to take effect [3][4]. Disclosure of Revised Articles - The full text of the revised articles of association and the related governance systems will be disclosed on the Shanghai Stock Exchange website [4].

Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss changes to its name, registered address, registered capital, and amendments to the Articles of Association [1][6] - The meeting will ensure the protection of shareholders' rights and maintain order and efficiency during the proceedings [1][2] Meeting Procedures - Only shareholders, their proxies, directors, supervisors, and other relevant personnel are allowed to attend the meeting, with the company having the right to refuse entry to others [2] - Shareholders and their proxies have the right to speak, inquire, and vote during the meeting, and must register their questions in advance [3][4] - Voting will be conducted through a combination of on-site and online methods, with results announced after counting [4][6] Proposed Changes - The company plans to change its name from "Guangdong Tiancheng Technology Co., Ltd." to "Shanghai Tiancheng Technology Co., Ltd." and increase its registered capital from RMB 83.957192 million to RMB 124.724524 million [8][9] - The registered address will also change to a new location in the Shanghai Free Trade Zone [8] - The amendments to the Articles of Association are necessary to align with the new name, address, and capital structure, while ensuring compliance with relevant laws and regulations [9]

PAN-CHINA Certifie d Public Accountants 浙江圣达生物药业股份有限公司 天健会计师 事务 所 Pan-China Certified Public Accountants | 目 录 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | ………………………………………………………… 一、验资报告 | 1—2 | | | | 页 | | | 第 | | 二、附件 | | | | | 页 | | | ………………………………………………………………第 3—13 | | （一）注册资本及实收股本变更前后对照表 | | | | | | 页 | | ………………………第 3 | | （二）验资事项说明 …………………………………………… | | | | | | 页 | | 第 4—5 | | （三）银行收款单和询证函复印件…………………………… 第 | | | | 页 | | | | 6—8 | | （五）本所执业证书复印件 ……………………………………… | | | | | | 页 ...

Group 1 - The company has approved a change in registered capital and corresponding amendments to its Articles of Association due to the implementation of the 2024 profit distribution plan and the conversion of convertible bonds into shares [1][2] - The registered capital will be increased from RMB 3,014,978,914 to RMB 3,316,485,099 as a result of the conversion of 52,000 yuan of convertible bonds into 7,540 shares [1][2] - The company plans to modify the relevant clauses in its Articles of Association to reflect the new registered capital amount, while other provisions will remain unchanged [2]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss a proposal regarding changes to registered capital and amendments to the Articles of Association [1][5][7] - The meeting will ensure the protection of shareholders' rights and maintain order during the proceedings [2][4] Meeting Procedures - Attendees must register and confirm their participation before the meeting starts, and latecomers will not be allowed to register [2][4] - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to specific guidelines to maintain order [2][3] - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][5] Agenda Items - The main agenda item is the proposal to change the registered capital from RMB 158,419,873 to RMB 205,674,335, which includes a capital increase of 47,254,462 shares [6][7] - The proposal requires a special resolution, needing approval from more than two-thirds of the voting rights held by attending shareholders [7]